![G. Kahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G. Kahn
Directeur/Membre du Conseil chez
SOLID BIOSCIENCES INC.
Fortune : 21 726 $ au 31/05/2026
Profil
G.
Clare Kahn is currently President at Clare Kahn Pharma Consulting LLC since 2016.
Independent Director at Solid Biosciences, Inc. since 2021.
Independent Director at Stoke Therapeutics, Inc. starting in 2026.
Formerly Vice President-Global Innovative Pharma at Pfizer Inc. from 2014 to 2016.
Vice President-Regulatory Affairs at GSK Plc from 1999 to 2010.
Chief Regulatory & Preclinical Development Officer at X-Vax Technology, Inc. from 2018 to 2019.
Assistant Professor at the University of Pennsylvania from 1981 to 1985.
Earned a doctorate from Royal Postgraduate Medical School in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 2 960 ( 0% ) | 21 726 $ | 31/05/2026 |
Postes actifs de G. Kahn
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Membre du Conseil | 02/03/2021 |
| STOKE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/04/2026 |
Clare Kahn Pharma Consulting LLC | President | 01/06/2016 |
Anciens postes connus de G. Kahn
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/06/2016 |
| GSK PLC | Conseiller Juridique Général | 01/01/2010 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1985 |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Directeur Technique/Scientifique/R&D | - |
Formation de G. Kahn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Royal Postgraduate Medical School
 Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clare Kahn Pharma Consulting LLC |
